Evidence-based interventions for perinatal mood and anxiety disorders: Rogers' August 2022 webinar

Perinatal mood and anxiety disorder (PMAD) is not only debilitating for women during pregnancy and the first 12 months postpartum, but can lead to socioeconomic burden, suicidal behaviors, and negative impacts on children and partners. Though evidence-based treatments exist, up to 86% of women experiencing PMAD do not receive the treatment they need. In this webinar, Rogers' Ajeng Puspitasari, PhD, LP, ABPP, and Hemalatha Rajanna, MD teach how to reduce barriers to treatment and increase access to care.